RCKT Rocket Pharmaceuticals Operatsion marja

RCKT (Rocket Pharma) - kompaniyaning tovar belgisi

Rocket Pharmaceuticals innovatsion gen terapiyalarini ishlab chiqadi, ularning kelajagi joriy savdo mavjud bo'lmagan sharoitda tartibga soluvchi organlar qarorlariga bog'liq. GURU.Markets tahliliy grafigidagi joriy operatsion marja 0.00 darajasini ko'rsatmoqda, bu esa xarajatlarning ta'sirini aks ettiradi. Biznes noyob nishda yuqori makro-barqarorlikka ega, biroq FDA tasdiqlashining kechikishi va tijorat ishga tushirishning surilishi xavflari aksiya narxiga bosim o'tkazmoqda.

RCKT: Rocket Pharma Sotuvning operatsion rentabelligi 04.07.2022 - 19.11.2026

Rocket Pharmaceuticals (RCKT) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning dastlabki tahlili:Rocket Corp, RCKT
Rocket Corp brendining mahsuloti

Rocket Pharmaceuticals (RCKT) kompaniyasining operatsion muvaffaqiyati uning operatsion marjasidagi o'zgarishlarda yaqqol aks etgan. Ushbu ko'rsatkich soliqlar va foiz majburiyatlarigacha bo'lgan asosiy biznes operatsiyalaridan olingan foyda ulushini o'lchaydi hamda tushumga nisbatan ichki xarajatlar boshqaruvining samaradorligini namoyish etadi. Kompaniyaga tegishli ushbu ko'rsatkich gen terapiyasi mahsulotlarining tijoratlashtirish bosqichiga o'tishining muhim belgisi hisoblanadi. Ushbu metrikaning o'sishi xarajatlar allaqachon hisobga olingan holda, mahsulotning muvaffaqiyatli ishga tushirilganini tasdiqlaydi.

Raqobatdosh kompaniyalar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik